P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
4.950
-0.360 (-6.78%)
At close: Oct 9, 2026, 4:00 PM EDT
4.932
-0.018 (-0.36%)
After-hours: Oct 9, 2026, 7:30 PM EDT
P3 Health Partners Revenue
P3 Health Partners had revenue of $386.38M in the quarter ending June 30, 2026, with 8.60% growth. This brings the company's revenue in the last twelve months to $1.50B, up 2.81% year-over-year. In the year 2025, P3 Health Partners had annual revenue of $1.46B, down -2.76%. That makes P3 Health Partners the 5,935th largest company in the world by revenue and 1,498th in the United States.
Revenue (ttm)
$1.50B
Revenue Growth
+2.81%
P/S Ratio
0.02
Revenue / Employee
$4,696,369
Employees
320
Market Cap
35.94M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.46B | -41.38M | -2.76% |
| Dec 31, 2024 | 1.50B | 234.08M | 18.48% |
| Dec 31, 2023 | 1.27B | 216.90M | 20.67% |
| Dec 31, 2022 | 1.05B | 563.93M | 116.14% |
| Dec 31, 2020 | 485.54M | 339.65M | 232.80% |
| Dec 31, 2019 | 145.89M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Community Health Systems | 11.98B |
| WW International | 665.49M |
| DocGo | 294.72M |
| Park Dental Partners | 251.37M |
| biote | 183.53M |
| AirSculpt Technologies | 150.72M |
| Concord Medical Services Holdings | 65.84M |
| The Joint | 58.55M |
PIII News
- 5 weeks ago - FORE Biotherapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - FORE Biotherapeutics Announces Positive Outcome from First Planned Interim Efficacy Analysis from FORTE Basket Study Evaluating Plixorafenib Monotherapy in Advanced Solid Tumors with BRAF Fusions - Business Wire
- 1 month ago - P3 Health Partners price target raised to $23 from $14 at Lake Street - TheFly
- 2 months ago - P3 Health Partners Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - P3 Health Partners Earnings release: Q2 2026 - Filings
- 2 months ago - P3 Health Partners Quarterly report: Q2 2026 - Filings
- 2 months ago - P3 Health Partners reports Q2 EPS (63c), consensus ($1.90) - TheFly
- 2 months ago - P3 Health Partners sees FY26 revenue $1.5B-$1.6B, consensus $1.52B - TheFly